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Factor V Leiden and superior
mesenteric artery occlusion:
A case study
Abstract
Factor V Leiden (FVL) is an inherited condition that prolongs the clotting
process; this subsequently places individuals at a higher risk of developing
a thromboembolism1. This case study will discuss a 41-year-old female who
developed a superior mesenteric artery occlusion with subsequent small
bowel ischaemia on a background of FVL. The discussion will illustrate the
rarity of an arterial occlusion, the risk factors that are associated with an
ischaemic small bowel, the implications of inheriting FVL and some of the
associated social aspects of an ileostomy.

Background
This case is important due to the rarity of an arterial occlusion, the risk factors
that place an individual at higher risk of developing such a diagnosis and
because it exposes some of the potential implications for a sufferer’s quality
of life. The prevalence of FVL is estimated to be 4–5 per cent of the general
population; however, FVL only increases the chances of developing a venous
thromboembolism if in conjunction with other associated risk factors2,3. This
case study aims to contribute to the literature examining the correlation
between FVL and an arterial occlusion2.

Case presentation
Mrs Jane Hopkins (pseudonym) is a
40-year-old woman who presented
to a regional hospital before being
transferred to a large metropolitan
hospital in Sydney after travelling to
the United States for a holiday. While
overseas, she was hospitalised with
severe abdominal pain requiring a
superior mesenteric artery (SMA)
stent in her previously inserted
superior mesenteric artery bypass
graft. She was discharged from the
United States hospital and had
returned home to Sydney for one
week before presenting to hospital
with further episodic abdominal
pain. During Jane’s admission she
was admitted in and out of the
intensive care unit, was hospitalised
for approximately three months
and underwent numerous surgical
procedures.

Her past medical history included
type two diabetes mellitus (T2DM),
peptic ulcer disease, depression and
anxiety, hyperlipidaemia, factor V
Leiden, two previous miscarriages
of unknown cause, a left brachial
artery thrombectomy in 2014, an
aortic superior mesenteric artery
bypass grafting and endarterectomy
in 2015 for atherosclerosis and
chronic abdominal angina, she is an
ex-smoker and was previously on the
contraceptive pill.
Her current medications consisted
of aspirin 100 mg daily, apixaban
5 mg twice daily which was newly
commenced in the United States
post stent, simvastatin 80 mg daily,
omeprazole 20 mg daily, metformin
500 mg twice daily and she was
prescribed ciprofloxacin and
metronidazole antibiotic course
that she recently finished after
stenting. The doses for these latter
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medications that Jane was prescribed
were not noted as they were
prescribed overseas. She commenced
Ibuprofen as a form of analgaesic,
there was no documentation to note
if this was suggested on discharge
from the United States hospital or
purchased over the counter. She has
an allergy to amoxicillin and bee
stings.
While in the regional hospital, Jane
was sent for a computed tomography
of abdomen and pelvis (CTAP) and
a computed tomography mesenteric
angiography (CTMA). Her lactate
was not measured on arrival at
hospital and her C reactive protein
(CRP) level was 34 mg/L. The CTMA
showed a patent SMA graft, so
Jane was subsequently admitted
under the colorectal team. While
in the emergency department (ED)
Jane developed tachycardia up
to 128 beats per minute and was
hypotensive with a blood pressure
of 92/65. Her abdominal pain was
worsening and she was clinically
deteriorating. Because of this Jane
underwent an emergency laparotomy
for a potential bowel resection for a
suspected ischaemic bowel.
During the procedure there was no
ischaemia found, but 30 cm of bowel
was removed as it was adhering
to the bladder, oedematous and
significantly thickened with fat
wrapping causing narrowing of the
lumen. Incidentally a 10 cm left-sided
ovarian cyst was noted and removed
by a consulting gynaecologist. She
was commenced on a heparin
infusion while off the apixaban.
Jane was kept nil by mouth with
intravenous (IV) therapy, had a Salem
sump nasogastric tube (NGT) in place
and was closely monitored postoperatively. On post-operative day
four, Jane’s pain worsened and she
had persistently high NGT output,
greater than 1.5 L per day. Her CRP
level was 425 mg/L and rising, she
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was persistently nauseated and
when trialled on sips of clear fluid
she would dry retch. In order to
investigate this deterioration, a
CTAP was re-ordered. The results
indicated further ischaemia. The
vascular team was consulted for their
input and a triple phase computed
tomography (3PCT) was ordered.
The 3PCT confirmed the SMA stent
was providing a reduced blood
supply; however, there was adequate
collateral blood flow. She was
showing signs of improvement by
this stage with reduced output from
her NGT, reduced nausea, improving
CRP and a lactate of 1.0 mmol/L.
Because Jane remained otherwise
clinically stable and improving, she
was commenced on total parenteral
nutrition (TPN) day six postoperatively and monitored closely for
any further signs of deterioration.
By day nine her NGT was removed, as
her NGT output was less than 300 ml
per day. She was commenced on a
full fluid diet, was haemodynamically
stable and feeling much improved.
The vascular team were still
frequently consulting Jane and
ordered a repeat 3PCT as a followup scan. The 3PCT diagnosed an
anastomotic leak and the vascular
team remained confident that there
was adequate collateral flow to
supply the small bowel. A family
meeting was held with discussion
about an ileostomy for the
anastomotic leak instead of a drain
insertion in interventional radiology
due to the risk of a fistula or further
complications.
On day 12 post-operatively Jane
returned to theatre for an exploratory
laparotomy. There was free fluid
intra-abdominally which was both
purulent and haemoserrous. It
was found that 50 cm of ileum was
ischaemic and subsequently resected,
which meant that a total of 80 cm
of small bowel had been removed.
The superior mesenteric artery was

unable to be visualised so it was
decided that the abdomen be left
open with negative pressure wound
therapy (NPWT) applied at -80 mmHg.
On day 14 after the initial operation
Jane went for a ‘second look’
laparotomy. An estimated 70 cm
of bowel appeared dusky but not
ischaemic; no bowel was resected
and it was decided that the vascular
team would investigate intraoperatively later that afternoon. She
returned to theatre and the vascular
team stated that her saphenous
vessel was not ideal for grafting and
the use of a prosthetic graft would
likely cause an infection because of
the current condition of the bowel.
After numerous attempts to flush the
superior mesenteric artery, a stent
was placed and an intra-operative
angiography was performed which
showed excellent flow. Additionally,
glyceryl trinitrate was used on the
small bowel vessels in an attempt to
improve blood flow with vasodilation4.
Jane’s abdomen was again left open
and NPWT was applied at -50mmHg.
On post-operative day 16, Jane went
back to theatre for an ileostomy
formation and abdominal closure. A
further 15 cm of bowel was resected
(now 95 cm in total) due to ischaemia,
a loop ileostomy was performed, and
her abdomen was closed.
Throughout Jane’s recovery her
ileostomy output remained high
despite the use of antidiarrheal and
antimotility agents. This was due
to short bowel syndrome. She was
unable to absorb many of her oral
medications as they were being
expelled whole due to the shortened
length of bowel and subsequent
faster transit time5,6. Because of this,
the haematology team ceased the
IV heparin and she was commenced
on a twice-daily dose of therapeutic
clexane for the treatment of her FVL.
The implications of an ileostomy
can dramatically affect one’s quality
of life. Jane was also managing
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an acute illness with subsequent
ICU admissions and a long-term
admission into a large metropolitan
hospital that was one hour away
from her home and family. She
required a mental health referral and
was diagnosed with major depressive
disorder.
Jane has a history of hyperlipidaemia
which worsened when commenced
on TPN. Her TPN formula and
administration regime was altered
and she was commenced on
fenofibrate as well as her regular
simvastatin. This is discussed in more
depth later in this case study.
Throughout her procedures
anatomical pathology was routinely
sent off for investigations. It was later
discovered that the initial ischaemia
was potentially caused by a
hydrophilic polymer emboli, thought
to have been from the superior
mesenteric artery graft stent placed
in the United States. Jane received a
bill for AU$115 000, which her travel
insurance company refused to pay as
they stated the medical issues were
caused from a prior condition. This is
also discussed in more depth later in
this study.

Differential diagnosis

Investigations

Jane was taking ibuprofen as her
analgesic despite her history of
peptic ulcer disease. Because of this
there was a possibility of gastritis
or a potential bleeding peptic ulcer.
A patient presenting with this will
usually present with epigastric pain
that is less severe than that of an
ischaemic bowel7. If they are actively
bleeding, they will present with
haematemesis or melena and will
have reduced levels of haemoglobin8.

Jane has known risk factors and a
correlating medical history consistent
with an ischaemic bowel. The
investigations in Table 1 (below) were
completed to diagnose this.

Jane also presented with a history
of persistent loose stools since
commencing antibiotics. A stool
sample was sent to screen for
Clostridium difficile. Antibiotic use is
a risk factor for obtaining Clostridium
difficile and Jane was on clindamycin9.
The use of proton pump inhibitors
also present with a correlation to
Clostridium difficile and she had
been on regular omperazole9. She
presented with common signs and
symptoms including diarrhoea,
nausea and abdominal pain. However,
her CT abdomen was not consistent
with such a presentation and her
previous history was more indicative
of ischaemic pathology.

Treatment
Jane underwent complex surgical
and pharmacological treatment as
described in Table 2 on the following
page and in further depth in the
discussion.

Outcome and follow-up
A reversal of Jane’s ileostomy is
planned. After approximately three
to six months, once her anastomosis
is believed to have adequately
rested and repaired and she is in
optimum health, Jane will have
an elective ileostomy reversal.
The stoma will be freed from the
abdominal wall and anastomosed
to the remaining colon14. Once the
ileostomy is reversed, Jane will no
longer require TPN as her short
bowel syndrome will likely resolve as
the reconnection of her small bowel
to her colon will reduce transit time.
If all goes well, Jane will be able to

Table 1: Diagnostic investigations
CTAP
(computed tomography
of abdomen and pelvis)

This can provide an in depth understanding of the bowel and the extent of bowel
compromise. This is usually performed prior to a CTMA as it will provide an indication of
bowel ischaemia10.

CTMA
(computed tomography
mesenteric
angiography)

A definitive diagnosis of an occlusion understandably relies upon demonstration of an
occlusion in imaging. A CTMA is performed when there is the intention for an endovascular
intervention. A contrast solution is injected and a total occlusion will show no filling of the
arteries while a partial occlusion will show vasoconstriction10.

3PCT
(triple phase computed
tomography)

This scan provides a greater understanding of blood flow and organ conditions as it is
performed in three phases: unenhanced, arterial and portal venous11.

Lactate

A normal lactate concentration is 0.5–1.5 mmol/L12. The lactate level elevates when there
is impaired tissue oxygenation to cells. Therefore, if ischaemia is evident an elevated
lactate level can be expected. However, an elevated lactate level is deemed a relatively
late sign in the course of the development of an ischaemic bowel7.

CRP
(C reactive protein)

Elevated levels of CRP indicate an acute or chronic inflammation within the body. A normal
CRP level is below 3.0 mg/L13.
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Table 2: Treatment
Exploratory laparotomy

A suspected ischaemic event, perforation or peritonitis warrants an emergency exploratory
laparotomy7. Jane went to theatre as she began to deteriorate while in the emergency
department and the suspected diagnosis was consistent with her medical history.

Anticoagulation

Once diagnosed with an SMA occlusion a patient will be managed on an IV heparin
infusion and their therapeutic range will be titrated based on their activated partial
thromboplastin time (APTT)7.

Repeat exploratory
laparotomy

Jane had a 3PCT and an anastomotic leak was noted. She returned to theatre and a bowel
resection was performed for ischaemic bowel. Her abdomen was then left open as a
second look laparotomy was indicated.

Stent insertion in
bypass graft

Jane previously had a bypass graft in 2015 for atherosclerosis that was causing chronic
abdominal angina due to a reduced blood supply. Her SMA bypass managed to be restented and her bowel was again left open for a second look laparotomy.

Ileostomy formation

Jane had an ileostomy formed in order to protect her anastomosis14. It will eventually be
reversed after her anastomosis has time to repair.

re-commence oral apixaban and
will no longer require twice daily
clexane. Jane will require ongoing
support from the mental health
team in the community; however,
once her quality of life has improved
there is hope that her requirements
for antidepressants will reduce and
hopefully cease.

Discussion
FVL is a blood disorder that is an
inherited genetic mutation. The
mutation can be present in one
chromosome or both to form a pair
suggesting it can be passed on from
one parent or both parents to their
children1. A person is heterozygous
for FVL if they inherited the mutation
from one parent, homozygous if
they inherited it from both parents.
In Jane’s case she was diagnosed
as heterozygous for FVL. Factor V is
required to allow for clotting to occur
in the body as a natural response
to injury. Fibrin will grasp platelets
to the site of injury to form a clot3.
Factor V aids with the release of
fibrin and when enough has been
released, protein C is released to
inactivate factor V. However, in
FVL factor V is resistant to protein
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C causing the clotting process to
continue on for a prolonged period
of time1,3.
Hydrophilic polymer is a type of
synthetic material used as the
coating on vascular devices such
as stents, sheaths and guide
wires15. Hydrophilic polymer has
unique properties that improve
biocompatibility while reducing
friction between vessel walls and
devices15,16. However, in more recent
years, hydrophilic polymer emboli
have been identified as a potentially
fatal iatrogenic complication16.
A study in 2018 found that a large
number of hydrophilic polymer
emboli have been reported from
the United States consistent with
Jane’s case. FVL causing an SMA
occlusion is deemed relatively
uncommon17. However, other studies
suggest the only mutations proven
to cause an arterial occlusion in
patients less than 55 years old are
FVL mutation, protein C and protein
S deficiencies18,19,20. Mortality rates of
a complete occlusion are 77–93 per
cent17. Consequently, patients should
be managed in an intensive care
setting with a multidisciplinary team

approach17,21. The multidisciplinary
teams should include haematology,
vascular, surgical and possibly
psychiatric involvement; this was
evident in Jane’s case. Best practice
for the investigation of a possible
SMA thrombus is a CTMA, which
was also completed during Jane’s
admission21. Other management
strategies are dependent upon the
extent of ischaemia 21. A second look
laparotomy, intravenous heparin in
the acute phase, progression to oral
anticoagulants when absorbency
is established, and vascular
management is dependent upon
the vessel damage21. Interventions
include fibrinolysis, angioplasty,
embolectomy, stenting and bypass
grafting2. A previously reported case
with a 32-year-old patient highlights
the rarity of the condition, imaging
difficulties and the importance
of obtaining a reliable history21,22.
Interestingly, studies suggest that
being diagnosed with FVL alone does
not predispose an individual to an
occlusion except if they have other
risk factors. In Jane’s case, she was
previously on the contraceptive pill
and is an ex-smoker with an SMA
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bypass graft and these are strong risk
factors of the condition.
The principal indicator for an
open abdomen is a second look
laparotomy; other indicators include
vascular injuries, swelling and the
risk of abdominal compartment
syndrome23. Optimisation of the
patient’s haemodynamic condition
between operations can lead
to potentially salvaging bowel
that once potentially appeared
ischaemic23,24. The current gold
standard for management of an open
abdomen is NPWT at a minimum
negative pressure; however, there is
discussion around this causing bowel
damage and further anastomotic
complications24,25. Conversely, a
retrospective study concluded that
non-open abdomen patients after
SMA occlusion more frequently
required a further bowel resection
at the second look, subsequent
short bowel syndrome and a higher
incidence of sepsis24.
Short bowel syndrome, also
commonly known as intestinal
failure, ensues when an extensive
amount of small bowel is resected
leading to an inadequate amount
remaining to absorb and manage the
patient’s nutritional and hydration
requirements5,6. The lessened surface
area of the bowel reduces the
interaction time of nutrients with
intestinal villi and the shortened
length of bowel subsequently causes
a faster transit time5. Short bowel
syndrome does not always occur after
resection. It is dependent on the
extent to which the bowel adapts its
functioning through morphologic and
functional changes and which part of
the bowel is resected26. The primary
therapy for short bowel syndrome
is TPN5. Often TPN can be weaned
once intestinal adaption begins or,
in Jane’s case, after her ileostomy
is reversed27. Being discharged on
TPN has a number of impacts on a
patient’s personal life. The patient

will have to understand how to use
their central venous access device
and how to use an IV pump, attend
frequent medical appointments,
change their eating habits, maintain
a strict fluid balance chart, manage
continuous surveillance of medical
issues and know when to seek
medical advice28. Jane had a Hickman
catheter inserted to manage her TPN,
her social life will be affected due
to TPN administration times, and
she is facing physical appearance
and self-confidence issues. Jane
has ongoing care from the mental
health team due to her history of
anxiety and depression and has
been commenced on antidepressant
medications.
Lipids are vital for numerous
physiological functions at a
cellular level. They regulate
permeability of cells, contribute
to cell membrane integrity and aid
pathways of the immune system29.
However, when there are too
many circulating lipids, conditions
known as hypercholesterolaemia
and hypertriglyceridaemia are risk
factors for cardiovascular disease
and TPN increases the risks of such
complications29,30. In a healthy adult,
lipids are broken down by lipoprotein
lipase (LPL) to be used as energy,
metabolised as required or stored
for future use. An ill individual’s LPL
release is reduced and subsequently
lipids continue to build in the blood29.
Such build-up of lipids may further
advance Jane’s atherosclerosis and
potentially occlude her recently restented SMA bypass graft. To manage
this, Jane’s cyclic TPN was changed
back to a 24-hour-a-day regime,
she was commenced on fenofibrate
145mg daily in conjunction with her
regular simvastatin and her fluid
balance was strictly managed.

Implications for practice
Jane was initially on aspirin 100
mg daily after her SMA bypass

graft in 2015. She was managed
with yearly ultrasounds. Studies
support the use of long-term oral
anticoagulants in conjunction
with a statin or at a minimum an
antiplatelet agent10. Lifestyle factors
should also be evaluated as they
can also significantly contribute
to cardiovascular health7. However,
being diagnosed with FVL alone
does not indicate the use of an
anticoagulant3,10 though when
exposed to other potential risk
factors such as surgical interventions
then anticoagulation should be
considered10.
There is little information about
long-haul air travel and FVL,
though regular leg exercises, the
use of compression stockings and
maintaining hydration is said to be
an adequate prevention strategy
if the patient has no significant
medical history3. However, Jane’s
history included a bypass graft and
studies support adequate longterm anticoagulation similar to
the treatment of atrial fibrillation10.
Jane will have to be discharged
on prolonged clexane due to her
short bowel syndrome leading
to an inability to absorb oral
anticoagulants10. She will also require
duplex ultrasounds three months
after stenting, six monthly following
that for two years, then yearly for the
remainder of her life31.
To manage Jane’s short bowel
syndrome a strict, self-managed
fluid balance chart will need to
be maintained to control her risk
of dehydration5. When rehydrating
with IV therapy it is essential to
monitor Jane’s electrolytes as
potassium and magnesium can be
easily lost via the ileostomy as the
small bowel re-absorbs fluids5,31.
Jane was encouraged to sip on an
oral electrolyte drink throughout
the day. Other factors were also
used in an attempt to reduce Jane’s
fluid loss. Antidiarrhoeals and
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antimotility agents such as psyllium
husk, loperamide, codeine, lomotil
and octreotide were used to reduce
gastric motility and subsequently to
prolong transit time6,31. Jane was also
already on a proton pump inhibitor;
however this was changed to IV
pantoprazole 40 mg twice a day to
prevent overgrowth of gut bacteria31.
Patients with short bowel syndrome
are at risk of multiple micronutrient
deficiencies, including vitamin B12,
other vitamins and electrolytes;
therefore, daily blood tests are
needed to closely monitor, evaluate
and manage micronutrient levels.
The TPN Clinical Nurse Consultant
(CNC) plays a significant role in
managing such deficiencies. This
nurse also plays an important role
in educating Jane and preparing her
to care for her Hickman catheter at
home, connect and disconnect from
TPN as well as linking her up with
government funding to support her
once she is discharged.
Although Jane’s ileostomy is
only short term, it will still have
detrimental effects on her quality
of life. It will change the way she
completes everyday activities – she
will have to manage wearing a stoma
bag under her clothes; manage
complications such as leaks, bag
changes and skin irritation; change
her diet and manage her social,
sexual and emotional functioning32.
Jane has a supportive long-term
partner who has taken time off
work to assist her in managing
practical skills with her stoma care,
TPN management and to support
her emotionally. Despite this, Jane
may still encounter issues with
self-image and confidence. Jane
was referred to the mental health
team who frequently consult with
her and her family as required. She
was commenced on fluoxetine 10
mg daily after being diagnosed
with major depressive disorder. The
fluoxetine was later increased to
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20 mg daily; this is consumed after
dissolving the tablets in water to
optimise absorption. The social
work department has been heavily
involved with supporting her with the
appropriate paperwork and legal aid
to challenge the insurance company’s
decision not to pay the medical bills
from the United States. The hospital
social worker is also involved in
liaising with her employer who is
holding her job for her while she is
on sick leave from work.

Statement
This case study follows and abides
by the Australian National Health
and Medical Research Council’s
definition of quality assurance. The
purpose of this case study was to
improve the quality of care provided
by health care professionals by
gaining a deeper understanding of
the conditions discussed. The case
study involved minimal risks and
inconvenience to the participant
whom signed a written consent. All
data collected has been de-identified
and the age, gender and country of
travel has been slightly altered for
confidentiality purposes.
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